FDA ‘rapidly working’ to finalize Moderna COVID-19 vaccine approval
FDA ‘rapidly working’ to finalize Moderna COVID-19 vaccine approval

FDA ‘rapidly working’ to finalize Moderna COVID-19 vaccine approval

More from Author Travis M. Andrews here: https://globelivemedia.com/author/travis-m-andrews/

The U.S. Food and Drug Administration is “rapidly” working to approve Moderna’s coronavirus vaccine, according to top officials at the agency.

The news surfaced shortly after an independent advisory panel to the FDA voted to endorse Moderna’s shot Thursday.

“Following today’s positive advisory committee meeting outcome regarding the Moderna COVID-19 vaccine, the U.S. Food and Drug Administration has informed the sponsor that it will rapidly work toward finalization and issuance of an emergency use authorization,” Dr. Stephen Hahn, FDA commissioner, and Dr. Peter Marks, head of the Center for Biologics Evaluation and Research, said in a joint statement.


“The agency has also notified the U.S. Centers for Disease Control and Prevention and Operation Warp Speed, so they can execute their plans for timely vaccine distribution.”

The panel’s vote on Thursday evening was 20-0. One committee member abstained.

Committee members voted to endorse the vaccine’s use in individuals ages 18 and older, while Pfizer received emergency approval last week for those ages 16 and up.

Upon formal FDA approval, which would mark the first such approval for Moderna, Americans could see an initial 6 million doses distributed next week.

Travis M. Andrews
Travis M. Andrews is a features writer for The Washington Post. He joined The Post in 2016 as a reporter for Morning Mix. He was previously a travel and culture editor for Southern Living magazine, a contributing pop culture reporter for Mashable and the Week, and a contributing editor for the Syfy blog Dvice. He also has freelanced for magazines, including Esquire, GQ and Time. He is the author of the coming book "Because He's Jeff Goldblum," a semi-rumination and semi-ridiculous look at the career of the enigmatic actor and an exploration of the shifting nature of fame in the 21st century, to be published in November by Plume.